What You Need to Know about Breast Implants
Breast augmentations are still by far the most popular cosmetic surgery procedure for women and have risen year on year. Still, there are risks associated with all breast implants, including:
- Additional surgeries
- Breast implant-associated-anaplastic large cell lymphoma (BIA-ALCL), which is a cancer of the immune system
- Systemic symptoms, commonly referred to as Breast Implant Illness (BII)
- Capsular contracture (scar tissue that squeezes the implant)
- Breast pain
- Rupture (tears or holes in the shell) of saline and silicone gel-filled implants
- Deflation (with visible change to breast size) of saline-filled implants
- Silent (without symptoms) rupture of silicone gel-filled implants
The longer you have breast implants, the greater the chances are that you will develop complications. This will require more surgery.
What You Need to Know about Breast Implants follows the article on 18th November 2019 provided statistical data showing the incidence of BIA-ALCL
, a type of cancer. The team found that the risk of BIA-ALCL for three implant brands was as follows:
one in 2596 patients with Silimed PU implants;
one in 3194 patients with Allergen Biocell implants; and
one in 6024 patients with Nagor implants.
The risk of BIA-ALCL is significantly higher for some types of breast implants than others.
At least 61 women
in the UK have been diagnosed with a potentially fatal cancer linked to breast implants, but the type they received continues to be used. There are no plans by the regulator to follow France and Australia in banning them.
We are bringing claims against clinics and doctors who carried out the surgery. It is clear that the textured implants linked to anaplastic large cell lymphoma
(ALCL) should be withdrawn from the market. Smooth implants are available instead, which have no proven connection to the cancer of the white blood cells.
In 2016,the World Health Organisation (WHO) defined a specific type of ALCL
called Breast Implant Associated Anaplastic Large Cell Lymphoma or BIA -ALCL. The MHRA then issued a warning to surgeons and clinics about the health risks.